NCT06445062 2026-03-13Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsRevolution Medicines, Inc.Phase 1/2 Recruiting1,130 enrolled
NCT02386397 2026-03-12BREGOInstitut du Cancer de Montpellier - Val d'AurellePhase 1/2 Completed66 enrolled
NCT07020221 2026-03-09A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsVerastem, Inc.Phase 1/2 Recruiting295 enrolled